IT Raids On Aurobindo Pharma; Sun Pharma To Announce Quarterly Results On Feb 13
Sat, 02/11/2012 - 07:38 | 
Aurobindo Pharma Ltd’s scrip dropped 5.67% on the Bombay Stock Exchange (BSE) on February 10 following reports of IT raids and sudden annulment of board conference.
Cambridge based Ironwood Pharmaceuticals has declared that it is offering up 5.3 million Class A scrips to aid toughen its balance sheet.
The ex biz development director of Takeda Pharmaceuticals International made $63,000 in profits from insider trading.
Sun Pharmaceuticals, India’s biggest drug manufacturer by market cap, is ready to declare its outcomes for the three month period ended December FY12 on February 13.
Tags: 